CEPETI Centro de Ensino e Pesquisa em Terapia Intensiva
Curitiba, Paraná 82530-200
0 studies enrolling now · 1 studies all time
What they study most
COVID-19
Studies at this site
A Study of Baricitinib (LY3009104) in Participants With COVID-19
— Completed